| Sep 29, 2025 |
Oct 1, 2025 |
MoonLake Immunotherapeutics
|
Other |
Sell |
15.0
|
-6,499,978
|
-76.52%
|
✗
|
$46.9M |
| May 15, 2025 |
May 19, 2025 |
OnKure Therapeutics, Inc.
|
Other |
Sell |
17.5
|
-1,813,439
|
-100.00%
|
✗
|
$3.4M |
| May 12, 2025 |
May 14, 2025 |
OnKure Therapeutics, Inc.
|
10% Owner |
Sell |
26.3
|
-24,300
|
-1.32%
|
✗
|
$48.2K |
| Apr 1, 2024 |
Apr 3, 2024 |
Immuneering Corp
|
10% Owner |
Sell |
17.5
|
-400,000
|
-12.14%
|
✗
|
$1.2M |
| Mar 14, 2024 |
Mar 18, 2024 |
Immuneering Corp
|
10% Owner |
Sell |
17.5
|
-909,091
|
-21.62%
|
✗
|
$2.7M |
| Oct 5, 2023 |
Oct 10, 2023 |
MoonLake Immunotherapeutics
|
10% Owner |
Buy |
77.5
|
+58,839
|
0.70%
|
✗
|
$3.5M |
| Oct 2, 2023 |
Oct 4, 2023 |
MoonLake Immunotherapeutics
|
10% Owner |
Buy |
95.0
|
+293,212
|
3.60%
|
✗
|
$16.8M |
| Mar 30, 2023 |
Apr 3, 2023 |
Biomea Fusion, Inc.
|
10% Owner |
Buy |
100.0
|
+400,000
|
12.61%
|
✗
|
$12M |
| Oct 25, 2021 |
Oct 27, 2021 |
Ventyx Biosciences, Inc.
|
10% Owner |
Buy |
100.0
|
+625,000
|
79.59%
|
✗
|
$10M |
| Oct 13, 2021 |
Oct 15, 2021 |
Pyxis Oncology, Inc.
|
Other |
Buy |
100.0
|
+450,000
|
67.28%
|
✗
|
$7.2M |
| Sep 17, 2021 |
Sep 21, 2021 |
Tyra Biosciences, Inc.
|
Other |
Buy |
100.0
|
+312,500
|
41.26%
|
✗
|
$5M |
| Aug 3, 2021 |
Aug 5, 2021 |
Immuneering Corp
|
10% Owner |
Buy |
100.0
|
+550,000
|
32.30%
|
✗
|
$8.3M |
| Jun 28, 2021 |
Jun 30, 2021 |
Monte Rosa Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+600,000
|
23.06%
|
✗
|
$11.4M |
| Apr 20, 2021 |
Apr 22, 2021 |
Biomea Fusion, Inc.
|
10% Owner |
Buy |
100.0
|
+900,000
|
39.63%
|
✗
|
$15.3M |
| Mar 30, 2021 |
Apr 1, 2021 |
Design Therapeutics, Inc.
|
Other |
Buy |
100.0
|
+750,000
|
17.18%
|
✗
|
$15M |
| Nov 23, 2020 |
Nov 23, 2020 |
Olema Pharmaceuticals, Inc.
|
10% Owner |
Buy |
100.0
|
+425,000
|
14.94%
|
✗
|
$8.1M |